A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan-Reference-Cited by-同舟云学术

A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan

Published:2015-09-01 Issue:47 Volume:36 Page:3332-3342
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Kimura Takeshi,Kozuma Ken,Tanabe Kengo,Nakamura Sunao,Yamane Masahisa,Muramatsu Toshiya,Saito Shigeru,Yajima Junji,Hagiwara Nobuhisa,Mitsudo Kazuaki,Popma Jeffrey J.,Serruys Patrick W.,Onuma Yoshinobu,Ying Shihwa,Cao Sherry,Staehr Peter,Cheong Wai-Fung,Kusano Hajime,Stone Gregg W.

Funder

Abbott Vascular

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/36/47/3332/17154893/ehv435.pdf

Reference20 articles.

1. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

2. Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

3. Simsek C Karanasos A Magro M Garcia-Garcia HM Onuma Y Regar E Boersma E Serruys PW van Geuns RJ . Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities. EuroIntervention 2014; E-pub ahead of print.